Comtech Telecommunications Corp. (NASDAQ: CMTL) shares are trading lower after the company reported worse-than-expected third-quarter sales results.
The company reported quarterly sales of $120.38 million which missed the analyst consensus estimate of $122.44 million.
Caribou Biosciences, Inc. (NASDAQ: CRBU) shares are trading lower after the company reported additional data from its CB-010 allogeneic CAR-T cell therapy Phase 1 ANTLER trial at the European Hematology Association 2022 Hybrid Congress.
Cogent Biosciences, Inc. (NASDAQ: COGT) shares are trading higher after the company reported initial data from its ongoing Phase 2 APEX clinical trial.